PIETRA, Claudio,LOVATI, Emanuela,RUSTUM, Youcef M.
申请号：
EP16770471
公开号：
EP3349855A1
申请日:
2016.09.16
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to therapeutic uses of elsiglutide, particularly for protecting and stimulating bone marrow and peripheral blood cell type activity or immune-response in patients compromised due to the administration of chemotherapeutic agents. The invention further provides uses of elsiglutide to enhance the antitumor activity of cytotoxic chemotherapeutic agents and target specific biological agents.
